09/11/2004 - 21:00

Imugene gains $250,000

09/11/2004 - 21:00

Bookmark

Upgrade your subscription to use this feature.
Imugene gains $250,000

IMUGENE is one of several Western Australian companies to receive a grant from the Federal Government’s Biotechnology Innovation Fund.

It has received $250,000 towards its work on developing an avian influenza vaccine for the commercial poultry industry.

The BIF grants varied from $82,000 to $250,000.

Eight other WA companies received grants through the BIF program.

Those companies were:

Agri Biotech received $224,125 for an antibody-based treatment for burns;

Medic Vision gaining $250,000 for the development of a virtual reality surgical simulation;

Bone Medical receiving $250,000 for the development of an oral hormone for the prevention and treatment of osteoporosis;

Ag-ID gaining $248,200 for a DNA detection and analysis process for livestock;

RXNet receiving $241,080 to develop a non-invasive blood glucose measuring device;

Phylogica getting $250,000 towards pre-clinical trialing of therapeutic leads for stroke;

Stirling Products receiving $239,275 for the commercialisation of its merino lamb growth hormone agent; and

Inner Vision Biometrics gaining $212,736 for its non-invasive magnetic resonance imaging test for liver fibrosis.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options